期刊文献+

脑动静脉畸形显微手术后周围脑组织IL-17A、TGF-β表达水平及意义 被引量:5

Expressions of transforming growth factor-β and interleukin-17A in peripheral brain tissue of nidus after microsurgical resection of brain arteriverous malformations and their significance
原文传递
导出
摘要 目的观察白细胞介素-17A(IL-17A)及转化生长因子-β(TGF-β)在脑动静脉畸形(AVM)显微手术后灶周脑组织中表达的变化及意义。方法前瞻性观察25例脑AVM患者IL-17A、TGF-β表达情况,其中12例患者血管内栓塞治疗后行显微手术切除,设为栓塞组;13例行单纯显微手术切除,设为未栓塞组。6例对照组脑组织为来源于外伤及脑出血内减压术后的正常脑组织标本。采用免疫组化和RT-PCR技术,检测AVM灶周脑组织IL-17A、TGF-β蛋白及mRNA的表达。结果与对照组比较,栓塞组及未栓塞组灶周脑组织的IL-17A蛋白及其mRNA表达明显增加,差异有统计学意义(P〈0.05):与未栓塞组比较,栓塞组IL-17A蛋白及mRNA表达明显减少,差异有统计学意义(P〈0.05)。与对照组比较,栓塞组与未栓塞组TGF-β蛋白及mRNA表达明显减少,差异有统计学意义(P〈0.051;与未栓塞组比较,栓塞组TGF-β蛋白升高不明显,差异无统计学意义(P〉0.05),TGB移mRNA明显升高,差异有统计学意义(P〈0.05)。结论IL-17A表达升高参与了AVM血管扩张及再通的临床病理过程,而TGF-β表达升高具有抑制栓塞后炎症反应的作用。 Objective To observe the expressions of interleukin-17A (IL- 17A) and transforming growth factor β (TGF-β) in the peripheral brain tissue of nidus after microsurgical resection of brain arterivenous malformations (AVM), and their significance. Methods We prospectively chose 25 patients with AVM; 12 of them were performed endovascular embolization and then microsurgical removal (Group A), and the other 13 were performed microsurgical removal only (Group B). Another 6 patients with traumatic brain injury and hypertensive cerebral hemorrhage that needed internal decompression were used as controls. The expressions of IL-17A and TGF-β in these brain tissues were detected by immunohistochemistry and P,T-PCR. Results The protein and mRNA expressions of IL-17A in Group A and B were significantly increased as compared with those in the controls (P〈0.05); the protein and mRNA expressions of IL-17A in Group A were significantly decreased as compared with those in Group B (P〈0.05). The protein and mRNA expressions of TGF-β in Group A and B were significantly decreased as compared with those in the controls (P〈0.05); the protein expression of IL-17A in Group A was not significantly increased as compared with that in Group B (P〉0.05); the mRNA expression of IL-17A in Group A was significantly increased as compared with that in Group B (P〈 0.05). Conclusion The increased expression of IL-17A might be associated with the growth and pathologic process of AVM; the increased expression of TGF-β might inhibit the inflammatory reaction after embolization.
出处 《中华神经医学杂志》 CAS CSCD 北大核心 2011年第10期1027-1030,共4页 Chinese Journal of Neuromedicine
基金 广东省医学科研基金(A2010155) 广东省科技计划项目(20098030801096)
关键词 脑动静脉畸形 白细胞介素-17A 转化生长因子-Β 栓塞 显微外科手术 Cerebral arteriovenous malformation Interleukin-17A Transforming growthfactor β Embolization Microsurgery
  • 相关文献

参考文献10

  • 1Friedlander RM. Clinical practice. Arteriovenous malformations of the brain[J]. N Engl J Med, 2007, 356(26): 2704-2712.
  • 2Natarajan SK, Ghodke B, Britz GW, et al. Multimodality treatment of brain arteriovenous malformations with microsurgery after embolization with onyx: single-center experience and technical nuances[J]. Neurosurgery, 2008, 62(6): 1213-1225.
  • 3Pawlikowska L, Tran MN, Achrol AS, et al. UCSF AVM Study Project. Polymorphisms in genes involved in inflammatory and angiogenic pathways and the risk of hemorrhagic presentation of brain arteriovenousmalformations [J]. Stroke, 2004, 35 (10): 2294-2300.
  • 4Kim H, Pawlikowska L, Chen Y, et al. Brain arteriovenous malformation biology relevant to hemorrhage and implication for therapeutic development[J]. Stroke, 2009, 40(3 Suppl): S95-97.
  • 5van Rooij WJ, Sluzewski M, Beute GN. Brain AVM embolization with Onyx[J]. AJNR Am J Neuroradiol, 2007, 28(1): 172-177.
  • 6Hartmann A, Mast H, Choi JH, et al. Treatment of arteriovenous malformations of the brain[J]. Curr Neurol Neurosci Rep, 2007, 7 (1): 28-34.
  • 7娄晓辉,余一骏,曾上飞,缪剑丹,郑海军,郑侠,杨瑞疆.脑动静脉畸形出血的显微手术治疗[J].实用医学杂志,2010,26(4):621-622. 被引量:7
  • 8李雪松,江楠,郭少雷,齐铁伟,王凌雁,梁丰,黄正松.脑动静脉畸形显微手术后周围脑组织血流变化及病理特征[J].中华显微外科杂志,2009,32(2):130-132. 被引量:15
  • 9Hashimoto T, Lawton MT, Wen G, et al. Gene microarray analysis of human brain arteriovenous malformations [J]. Neurosurgery, 2004, 54(2): 410-423.
  • 10Bossier AD, Richards J, George C, et al. Novel mutations in ENG and ACVRL1 identified in a series of 200 individuals undergoing clinical genetic testing for hereditary hemorrhagic telangiectasia (HHT): correlation ofgenotype with phenotype [J]. Hum Murat, 2006, 27(7): 667-675.

二级参考文献16

  • 1张文兰,马晓民,金娟.CT、DSA和MRI诊断脑动静脉畸形[J].中国医学影像学杂志,2005,13(4):310-313. 被引量:21
  • 2陆永建,任天剑,何伟文,李明昌,陈唏,伍健伟,方泽鲁,朱建堃.103例脑动静脉畸形的临床特点及显微外科治疗[J].中华神经医学杂志,2006,5(6):618-619. 被引量:9
  • 3樊新颖,徐格林,刘新峰.脑过度灌注综合征的监测[J].中华神经医学杂志,2006,5(9):968-970. 被引量:4
  • 4姚国杰,秦尚振,马廉亭,徐国政,龚杰,余泽,杨铭.脑动静脉畸形破裂出血的急诊显微手术治疗[J].中国临床神经外科杂志,2006,11(11):670-671. 被引量:11
  • 5Brown RD Jr, Flemming KD, Meyer FB, et al. Natural history, evaluation, and management of intracranial vascular malformations. Mayo Clin Proc,2005,80:269 - 281.
  • 6Van Rooli WJ, Sluzewski M, Beute GN. Brain AVM embolization with Onyx. Am J Neuroradiol,2007,28:172 - 177.
  • 7Natarajan SK, Ghodke B, Britz GW,et al. Multimodality treatment of brain arteriovenous malformations with microsurgery after embolization with onyx: single-center experience and technical nuances. Neurosurgery, 2008,62: 1213 - 1225.
  • 8Friedlander. Arteriovenous malformation of the brain. N Engl J Med, 2007,356 : 2704 - 2712.
  • 9Ogilvy CS, Stieg PE, Awad I, et al. AHA Scientific Statement : Recommendations for the management of intracranial arteriovenous malformations: a statement for health-care professionals from a special writing group of the Stroke Council, American Stroke Association. Stroke, 2001,32 : 1458 - 1471.
  • 10Natarajan SK, Ghodke B, Britz GW, et al. Muhimodality treatment of brain arteriovenous malformations with microsurgery after embolization with onyx: single-center experience and technical nuances. Neurosurgery, 2008,2: 1213 - 1225.

共引文献20

同被引文献49

  • 1赵臣,李永哲,夏薇,刘定华,胡朝军,佟大伟,张蜀澜.系统性红斑狼疮患者转化生长因子β1及其Ⅱ型受体的表达及意义[J].中华检验医学杂志,2006,29(9):791-792. 被引量:3
  • 2Yoshimura A, Muto G. TGF-[3 function in immune suppression [J]. Curr Top Microbiol Immunol, 2011,350: 127-147.
  • 3Elbeldi-Ferchiou A, Ben Ahmed M, Smiti-Khanfir M, etal. Resistance to exogenous TGF-[3 effects in patients with systemic lupus erythematosus [J].J Clin Immunol, 2011,31 (4) : 574-583.
  • 4Becker-Merok A, Eilertsen G 0, Nossent J C. Levels of transforming growth factor-beta are low in systemic lupus erythematosus patients with active disease [J]. J Rheumatol, 2010,37(10) : 2039-2045.
  • 5Kohut E, Hajdu M, Gergely P, et al. Expression of TGFbetal and its signaling components by peripheral lymphocytes in systemic lupus erythematosus [J].Pathol Oncol Res, 2009,15 (2) :251-256.
  • 6Xie S, Ding L, Xiong Z, et al. Implications of Thl and Th17 ceils in pathogenesis of oral lichen planus [J]. J Huazhong Univ Sci Technolog Med Sci, 2012,32(3) :451-457.
  • 7Lowes MA, Kikuchi T, Fuentes-Duculan J, et al. Psoriasis vulgaris lesions contain discrete populations of Thl and Thl7 T cells [ J ]. J Invest Dermatol, 2008,128 (5) : 1207-1211.
  • 8Elson CO, Cong Y, Weaver CT, et al. Monoclonal anti- interleukin 23 reverses active colitis in a T cell-mediated model in mice [ J ]. Gastroenterology, 2007,132 (7) : 2359-2370.
  • 9Schutyser E, Struyf S, Van Damme J. The CC chemokine CCL20 and its receptor CCR6 [J]. Cytokine Growth Factor Rev, 2003, 14(5) :409-426.
  • 10Harper EG, Guo C, Rizzo H, et al. Thl7 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis [J]. J Invest Dermatol, 2009,129(9) :2175-2183.

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部